Corteva, INC

Market Movers (8-K)

NYSE
Corteva, Inc. announced robust financial results for the first half of 2026, exceeding expectations and leading to an increased full-year financial outlook, while remaining on track for its planned separation.
Better than expected
NYSE
Corteva Inc. has announced the intended boards of directors for its two future independent companies, Corteva and Vylor, as part of its planned separation in Q4 2026.
NYSE
Corteva, Inc. has updated its Crop Protection restructuring program, increasing total expected pre-tax charges to between $750 million and $815 million.
Worse than expected
NYSE
Corteva, Inc. announced robust first-quarter 2026 financial results, driven by strong performance in its Seed and Crop Protection segments, and reaffirmed its full-year 2026 financial guidance.
NYSE
Corteva, Inc. announced the results of its Annual Meeting, where stockholders re-elected all 12 director nominees, approved executive compensation, and ratified PricewaterhouseCoopers LLP as its independent auditor.
NYSE
Corteva, Inc. announced the executive leadership teams for its two future independent companies, New Corteva (crop protection) and SpinCo (seed and genetics), ahead of their planned separation.

Quarterly Earnings (10-Q)

NYSE
Corteva, Inc. announced its second quarter 2026 financial results, showing a slight decrease in net sales but an increase in operating EBITDA, while managing ongoing restructuring and legal matters.
NYSE
Corteva reported strong Q1 2026 growth with net sales up 11% to $4.9 billion while advancing its planned business separation.
NYSE
Corteva reports strong third-quarter and year-to-date 2025 financial results, driven by volume growth and cost efficiencies, alongside a plan to separate its Seed and Crop Protection businesses.
Capital raise
Better than expected
NYSE
Corteva, Inc. reported a significant increase in net income and earnings per share for the second quarter and first half of 2025, driven by strong volume growth, strategic pricing, and cost efficiencies.
Capital raise
Better than expected
NYSE
Corteva's Q1 2025 earnings surged despite a slight sales decrease, fueled by strategic pricing in the Seed segment and effective cost management initiatives.
Better than expected
NYSE
Corteva's third-quarter results show a net loss, impacted by pricing pressures and restructuring charges, despite some volume growth in Crop Protection.
Worse than expected

Annual Reports (10-K)

NYSE
Corteva, Inc. reported significant financial improvements in 2025, including a 3% net sales increase and a 14% rise in operating EBITDA, while announcing plans to separate its Seed and Crop Protection businesses into two independent public companies by late 2026.
Better than expected
Capital raise
NYSE
Corteva's 2024 results show a slight dip in net sales due to pricing pressures in crop protection, offset by volume increases in seed and cost-saving measures.
Worse than expected
NYSE
Corteva, Inc. and its subsidiary EIDP, Inc. have released their combined 2023 annual results, showing a slight decrease in net sales but an increase in operating EBITDA.
Worse than expected

Insider Trading (Form 4)

NYSE
Christopher J. Policinski, a Director of Corteva, Inc., received 413 shares of common stock on July 31, 2026.
NYSE
Nayaki R Nayyar, a Director of Corteva, Inc., received 413 shares of common stock on July 31, 2026.
NYSE
Janet Plaut Giesselman, a Director of Corteva, Inc., received 98 shares of common stock on July 31, 2026.
NYSE
Corteva, Inc. executive Luther C. Kissam IV reported the acquisition of 24,138 shares of common stock on June 1, 2026, with no cost basis.
NYSE
Director Nayaki Nayyar acquired 401.185 shares of Corteva, Inc. common stock through a deferred compensation plan.
NYSE
Director Marcos M. Lutz of Corteva, Inc. reported the withholding of 906 shares to satisfy tax obligations related to restricted stock unit vesting.

Proxy Statements (Def-14A)

NYSE
Corteva, Inc. announces solid 2025 financial results, significant shareholder returns, and proposes a refreshed board slate for its upcoming April 28, 2026 Annual Stockholder Meeting.
Better than expected
NYSE
Corteva, Inc. is soliciting stockholder votes on the election of directors, approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as its independent auditor for 2025.
NYSE
Corteva's 2025 proxy statement outlines key agenda items for the annual stockholder meeting, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor.
NYSE
Corteva Inc. announces its 2024 Annual Meeting of Stockholders, urging investors to vote on key proposals including the election of directors, executive compensation, and ratification of the company's accounting firm.
NYSE
Corteva, Inc. releases its proxy statement outlining the agenda for the 2024 Annual Stockholder Meeting, including director elections, executive compensation approval, and a certificate of incorporation amendment.

Schedule 13G - Passive Investments

NYSE
Capital World Investors has reported beneficial ownership of 36,863,390 shares, representing 5.5% of Corteva, Inc.'s common stock as of March 31, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.2% of Corteva Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.56% in Corteva Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Corteva Inc. following an internal realignment that disaggregated reporting.
NYSE
State Street Corporation has disclosed a 5.2% beneficial ownership in Corteva Inc., holding significant shared voting and dispositive power.
NYSE
State Street Corporation has disclosed a 5% beneficial ownership stake in Corteva Inc., holding over 34 million shares of common stock.